Abstract
Malaria, caused by Plasmodium falciparum, remains a significant health burden. One major barrier for developing antimalarial drugs is the ability of the parasite to rapidly generate resistance. We previously demonstrated that salinipostin A (SalA), a natural product, potently kills parasites by inhibiting multiple lipid metabolizing serine hydrolases, a mechanism that results in a low propensity for resistance. Given the difficulty of employing natural products as therapeutic agents, we synthesized a small library of lipidic mixed alkyl/aryl phosphonates as bioisosteres of SalA. Two constitutional isomers exhibited divergent antiparasitic potencies that enabled the identification of therapeutically relevant targets. The active compound kills parasites through a mechanism that is distinct from both SalA and the pan-lipase inhibitor orlistat and shows synergistic killing with orlistat. Our compound induces only weak resistance, attributable to mutations in a single protein involved in multidrug resistance. These data suggest that mixed alkyl/aryl phosphonates are promising, synthetically tractable antimalarials.
| Original language | English |
|---|---|
| Pages (from-to) | 1714-1728.e10 |
| Journal | Cell Chemical Biology |
| Volume | 31 |
| Issue number | 9 |
| Early online date | 12 Aug 2024 |
| DOIs | |
| Publication status | Published - 19 Sept 2024 |
Funding
This work was supported in part by the NIH ( R33 AI127581 , to DAF and MB, R01 AI109023 to D.A.F) and by Department of Defense grant ( W81XWH2210520 to D.F. and M.B.). V.L.L. was supported by NIH training grant T32 GM113854 . The work was also supported by funding to M.J.B. from the Wellcome Trust ( 220318/A/20/Z ) and the Francis Crick Institute ( https://www.crick.ac.uk/ ) which receives its core funding from Cancer Research UK ( CC2129 ), the UK Medical Research Council ( CC2129 ), and the Wellcome Trust ( CC2129 ).
| Funders | Funder number |
|---|---|
| Medical Research Council | |
| Francis Crick Institute | |
| Cancer Research UK | CC2129 |
| U.S. Department of Defense | W81XWH2210520, T32 GM113854, W81XWII2210520 |
| National Institutes of Health | R33 AH27581, R01 AI109023, R33 AI127581 |
| Bill & Melinda Gates Foundation | INV-033538 |
| The Wellcome Trust | 220318/A/20/Z |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Plasmodium falciparum
- activity-based probes
- alky/aryl phosphonates
- covalent probes
- drug resistance
- lipid metabolism
- serine hydrolases
ASJC Scopus subject areas
- Biochemistry
- Molecular Medicine
- Molecular Biology
- Pharmacology
- Drug Discovery
- Clinical Biochemistry
Fingerprint
Dive into the research topics of 'Mixed alkyl/aryl phosphonates identify metabolic serine hydrolases as antimalarial targets'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS